Plain-English translation of NCT07660731 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new experimental medicine called for the first time in people. Researchers want to understand how safe it is, how your body processes it, and whether food or other medicines affect how it works. The study includes healthy volunteers and people with mild-to-moderate asthma.
Before any new medication can be used to treat patients, it must first be tested carefully in people to make sure it is safe and that the body can tolerate it. This is an early-stage study designed to gather that important safety information.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the study you join, you will take the medication by mouth either as a single dose or once daily for 14 days at the study clinic. The study has six different parts, each designed to answer different questions about how the medication works in the body. Your participation may include blood tests, visits to the clinic, and time spent at the research facility so researchers can monitor how you respond to the treatment.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
United States